Search

everythinglearnresearchcommunity

for

Search:↓

Stem cells could potentially rebuild missing structures in wounds, improving facial skin replacement techniques.

Eyebrow hair transplants in patients with frontal fibrosing alopecia may look good at first but often lose the new hair after a few years.

Hair transplantation using micrografts and minigrafts is effective and safe for facial and scalp reconstruction with natural-looking results.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

A new severe form of monilethrix syndrome includes hair loss, scalp itching, cataracts, and distinct facial features.

Low-dose oral minoxidil for hair loss can cause mild excessive hair growth, usually appearing within the first 3 months, but it can be managed by adjusting the dose or removing the unwanted hair, with most people not needing to stop the treatment.

Robotic technology greatly improves cosmetic dermatology outcomes and patient satisfaction.

Replenishing iron after phlebotomy can cause relapse in porphyria cutanea tarda.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

The document recommends personalized, culturally sensitive treatments to rejuvenate the aging Asian face, focusing on natural results and specific techniques for skin, hair, and facial features.

Secondary facelifts or neck lifts should focus on deep layer support rather than just tightening skin for a natural look.

Papular mucinosis can cause eyebrow hair loss, but treatment can lead to regrowth.

PRP combined with minoxidil is the most effective and safe treatment for male pattern baldness.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Endocrine diseases in children can cause various skin and hair changes.

Ethnic Indian women with PCOS often have early symptoms, delayed diagnosis, and need better information and support for treatment and lifestyle management.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

A rare benign cheek tumor was successfully removed from a 15-year-old girl without complications or recurrence.

Low-dose oral minoxidil improved hair growth in a woman with short anagen syndrome.

Platelet-Rich Fibrin (PRF) can speed up healing in chronic wounds, improve hair density, and act as a natural filler for skin rejuvenation, but its use in hair loss treatment needs more evaluation.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Surgery removed an ovarian tumor, improving her symptoms and normalizing testosterone levels.

Understanding Polycystic Ovary Syndrome (PCOS) and its causes can lead to effective treatments.

Minoxidil can treat hair loss with topical, oral, and sublingual options, offering personalized choices.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Cosmeceuticals like sunscreens may trigger frontal fibrosing alopecia, but more research is needed.